Support of the Sexual Health in Oncology

Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03166774
Collaborator
(none)
0
12

Study Details

Study Description

Brief Summary

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health.

There is a counselling team (nurse, esthetician,sexologue..etc) to raise the subject with patient and partner .

Finally, the oncologist continue during the treatment to evaluate the benefit of this program and adapt their counselling according to the needs

Condition or Disease Intervention/Treatment Phase
  • Other: Program of support of the sexual health

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Support of the Sexual Health in Oncology
Actual Study Start Date :
Jun 6, 2016
Actual Primary Completion Date :
Jun 6, 2017
Anticipated Study Completion Date :
Jun 6, 2017

Arms and Interventions

Arm Intervention/Treatment
patient consulting in oncology ervice

Program of support of the sexual health in oncology by questionnaire

Other: Program of support of the sexual health
Patients included in the study have to answer to a questionnaire

Outcome Measures

Primary Outcome Measures

  1. Benefit of the care measurement program [Day 1]

    assessment of data recorded on questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • all patient consulting in oncology service

  • age > 18 years

  • accepting to participate

Exclusion Criteria:
  • Age< 18 years

  • Refusing to participate

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Groupe Hospitalier Paris Saint Joseph

Investigators

  • Principal Investigator: Alexandra SCHULTZ, Psychologist, Groupe Hospitalier Paris Saint Joseph

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Groupe Hospitalier Paris Saint Joseph
ClinicalTrials.gov Identifier:
NCT03166774
Other Study ID Numbers:
  • AssO
First Posted:
May 25, 2017
Last Update Posted:
Aug 9, 2018
Last Verified:
Aug 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2018